Ex Vivo Organ Care System
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/006,871, filed Jun 2, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,154,050 | Ex Vivo Organ Care System In force · Medium confidence | Transmedics, Inc. | In force | Medium confidence | ||
| US 11,903,381 | Ex Vivo Organ Care System In force · Medium confidence | Transmedics, Inc. | In force | Medium confidence | ||
| US 11,944,088 | Ex Vivo Organ Care System In force · Medium confidence | Transmedics, Inc. | In force | Medium confidence | ||
| US 10,076,112 | Ex Vivo Organ Care System In force · High confidence | Transmedics, Inc. | In force | High confidence | ||
| Application 18/402,476 | Ex Vivo Organ Care System Pending Not granted | Transmedics, Inc. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Transmedics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.